Tubulin tyrosine ligase variant perturbs microtubule tyrosination, causing hypertrophy in patient-specific and CRISPR gene-edited iPSC-cardiomyocytesPerundurai S. Dhandapany(Institute for Stem Cell Biology and Regenerative Medicine)JCI InsightAugust 8, 202510.1172/jci.insight.187942Cited by 3SaveCiteExport RISWatch citationsRelated PapersSleep fragmentation induces heart failure in a hypertrophic cardiomyopathy mouse model by altering redox metabolism|iScience|2024|7KCNA2 variants cause dilated cardiomyopathy, obesity and sleep apnea through RAC-ERK pathway|EMBO Molecular Medicine|2026|0